Careers      Contact Us



Building a strong company that will create a healthy Africa, where all Africans have an opportunity to make their own success happen. 




To be the number one leader in quality regional healthcare in West Africa, with the largest product portfolio and biggest market share, using good people, innovative products and world-class facilities to successfully create, produce and sell all we do.




Our work philosophy is clear. We begin everything with quality – we design it into every product, embed it into every process, and teach it to every employee, to ensure high quality healthcare with excellent outputs that meet or exceed any stringent regulatory requirements and ensure customer satisfaction.


Our Story
UNAIDS Executive Director Michele Sidibe tours Danadams Pharmaceuticals in February and calls for Government to invest more in local manufacturing.

The Minister of Health and the Parliamentary Committee for Health also toured Danadams in March 2012 and pledge support for local manufacturing.

West Africa International Magazine awards us the Most Innovative & Multipurpose Pharmaceutical Company in West Africa 2011

In Europe, we're recognized with the International Arch of Europe Gold Award for Demonstrated Excellence and Sustainability 2011, as well as the Majestic Five Continents Award for Quality and Excellence 2011

Ghana Club 100 chooses us as Leader in the Manufacturing Sector, and we retain our 6th overall rank among Club 100 companies based on profitability and growth performance from 2008 to 2010.
Our commitment to quality and excellence pays off when the Ghana Investment Promotion Centre (GIPC) adjudges Danadams as number one leader in Ghana's Health Sector and we are ranked overall at 6th position among the Club 100 Companies.

Our CEO is selected by the Entrepreneurs Foundation of Ghana as the winner of the Best Entrepreneur Health Services Award for 2010.

We also receive international acclaim, winning the 20th Golden Award for Business Excellence 2010 from the Trade Leaders Club in Europe.
West African Health Organization (WAHO) awards a US $1.2 million contract to Danadams to provide ARVs to Togo and Gambia. Drug Regulators from Togo and Gambia inspect and approve our plant facility.

WAHO helps us engage Price Waterhouse Coopers to prepare a 5-Year Business Plan for Danadams (2009-2014) which points to continued positive growth.

United Nations Industrial and Development Organization (UNIDO) sends Michel Gouy and Dr Harald Orth from its Technical Assistance team to do a Field Visit inspection.
We decide to pursue World Health Organization (WHO) Prequalification Status – a global standard of excellence.

The WHO Technical Assistance Program sends Dr Patrick Hoet to review and provide counseling on the implementation of GMP according to WHO requirements, while his colleague Dr Ekkehard Michahelles completes a Factory Technical inspection for us.
Roche Pharmaceuticals and the Aids Technology Transfer Initiative coordinate an advisory visit to our company.

We pass a factory inspection by Drug Regulators from Cote d'Ivoire and register five more brands.
We register our first products in other West African countries: Burkina Faso, Sierra Leone, Liberia, and Democratic Republic of the Congo.

Germany's development corporation, GTZ, commissions European technical inspections of our factory and dossiers, and engages KPMG to do a feasibility study for Danadams.
On 8 June2005, His Excellency J.A. Kufour (then President of Ghana) commissions our manufacturing facility in Baatsona, Accra. We receive authorization for seven anti-retrovirals and become the first company in Ghana to produce generic ARVs.

We register 14 products for market at the Food and Drugs Board including anti-malarials, analgesics, anthelmintics and antibiotics.

To ensure our quality standards, we obtain external QA validation reports from North West University in South Africa for key Danadams products.





© 2011. Danadams